Mechanisms of Radiosensitization by the Neurotensin Receptor Antagonist SR48692 in Prostate Cancer Models

2009 ◽  
Author(s):  
Jaroslaw Dziegielewski
Keyword(s):  
Prostate Cancer ◽  
Receptor Antagonist ◽  
Neurotensin Receptor ◽  
Cancer Models

Mechanisms of Radiosensitization by the Neurotensin Receptor Antagonist SR48692 in Prostate Cancer Models

2010 ◽  
Author(s):  
Jaroslaw Dziegielewski ◽  
Nicholas C. Valerie ◽  
John DaSilva ◽  
Eli V. Casarez ◽  
Amol S. Hosing ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Receptor Antagonist ◽  
Neurotensin Receptor ◽  
Cancer Models

scholarly journals Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models

2019 ◽  
Vol 145 (5) ◽  
pp. 1382-1394 ◽  
Author(s):  
Tatsuo Sugawara ◽  
Simon J. Baumgart ◽  
Ekaterina Nevedomskaya ◽  
Kristin Reichert ◽  
Holger Steuber ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Androgen Receptor Antagonist ◽  
Cancer Models

Abstract 2505: Neurotensin receptor antagonist, SR48692, sensitizes prostate cancer cells to radiationin vitroandin vivo

2011 ◽  
Author(s):  
Eli V. Casarez ◽  
John O. DaSilva ◽  
Nicholas C.K. Valerie ◽  
Suresh Anaganti ◽  
Marya E. Dunlap-Brown ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Receptor Antagonist ◽  
Cancer Cells ◽  
Prostate Cancer Cells ◽  
Neurotensin Receptor

1032 poster MLN8054, A NOVEL INHIBITOR OF AURORA KINASE A SENSITIZES ANDROGEN-RESISTANT PROSTATE CANCER MODELS TO RADIATION

2011 ◽  
Vol 99 ◽  
pp. S386
Author(s):  
L. Moretti ◽  
K. Niermann ◽  
S. Schleicher ◽  
K.W. Kim ◽  
P. Kopsombut ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Aurora Kinase ◽  
Aurora Kinase A ◽  
Cancer Models ◽  
Kinase A
Sign in / Sign up

Export Citation Format

Share Document